| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |